BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31407105)

  • 1. Sericin Inhibits Devitrification of Amorphous Drugs.
    Salunkhe N; Jadhav N; More H; Choudhari P
    AAPS PharmSciTech; 2019 Aug; 20(7):285. PubMed ID: 31407105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of drug-sericin solid dispersions for improved solubility and dissolution.
    Salunkhe NH; Jadhav NR; More HN; Jadhav AD
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1683-1691. PubMed ID: 29030184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Synergetic Effects of Nonpolar and Polar Protic Solvents on the Properties of Felodipine and Soluplus in Solutions, Casting Films, and Spray-Dried Solid Dispersions.
    Chen Y; Huang W; Chen J; Wang H; Zhang S; Xiong S
    J Pharm Sci; 2018 Jun; 107(6):1615-1623. PubMed ID: 29454624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the properties of felodipine solid dispersions prepared by different technologies].
    Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Spray-Dried Particle Morphology on Mechanical and Flow Properties of Felodipine in PVP VA Amorphous Solid Dispersions.
    Ekdahl A; Mudie D; Malewski D; Amidon G; Goodwin A
    J Pharm Sci; 2019 Nov; 108(11):3657-3666. PubMed ID: 31446144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.
    Ambike AA; Mahadik KR; Paradkar A
    Pharm Res; 2005 Jun; 22(6):990-8. PubMed ID: 15948043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of processing on the surface physical stability of amorphous solid dispersions.
    Yang Z; Nollenberger K; Albers J; Moffat J; Craig D; Qi S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):897-908. PubMed ID: 25111184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.
    Adebisi AO; Kaialy W; Hussain T; Al-Hamidi H; Nokhodchi A; Conway BR; Asare-Addo K
    Colloids Surf B Biointerfaces; 2016 Oct; 146():841-51. PubMed ID: 27451373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moringa coagulant as a stabilizer for amorphous solids: Part I.
    Bhende S; Jadhav N
    AAPS PharmSciTech; 2012 Jun; 13(2):400-10. PubMed ID: 22359158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
    Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
    Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation of felodipine/zein amorphous solid dispersions and in vitro evaluation using a dynamic gastrointestinal system.
    Zhang H; Liu X; Ma X
    Pharm Dev Technol; 2020 Dec; 25(10):1226-1237. PubMed ID: 32787680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance.
    Puppolo MM; Hughey JR; Dillon T; Storey D; Jansen-Varnum S
    AAPS PharmSciTech; 2017 Nov; 18(8):2841-2853. PubMed ID: 28560506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
    Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
    Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine.
    Fu J; Cui L; Yang C; Xiong H; Ren G; Ma X; Jing Q; Ren F
    AAPS PharmSciTech; 2018 Apr; 19(3):1231-1242. PubMed ID: 29302871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.